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A low-copy component of mammalian reovirus particles is μ2, an 83-kDa protein encoded by the M1 viral genome segment and packaged
within the viral core. Previous studies have identified μ2 as a nucleoside triphosphate phosphohydrolase (NTPase) as well as an RNA 5′-
triphosphate phosphohydrolase (RTPase), putatively involved in reovirus RNA synthesis and/or 5′-capping. Other studies have identified μ2 as a
microtubule-binding protein, which also associates with the viral factory matrix protein μNS and thereby anchors the factories to cellular
microtubules during infections by most reovirus strains. To extend studies of μ2 functions during infection, we tested a small interfering RNA
(siRNA) directed against the M1 plus-strand RNAs of reovirus strains Type 1 Lang (T1L) and Type 3 Dearing (T3D). The siRNA strongly
suppressed μ2 expression by either strain and reduced infectious yields in a strain-dependent manner. This first strain difference was genetically
mapped to the M1 genome segment and tentatively assigned to a single μ2 sequence polymorphism, Pro/Ser208, which also determines a T1L–
T3D strain difference in microtubule association. The siRNA-based defect in μ2 expression was rescued by plasmids, containing silent mutations
in the siRNA-targeted sequence, which encoded either T1L or T3D μ2, but the growth defect was rescued only by T1L μ2. This second strain
difference was also mapped to Pro/Ser208, in that swapping this one residue between T1L and T3D μ2 reversed the rescue phenotypes. Thus, the
T1L–T3D strain difference in μ2–microtubule association was correlated not only with the extent of reduction in infectious yields by the siRNA
but also with the extent of rescue by plasmid-derived μ2. In addition, the rescue capacity of T1L μ2 was abrogated by nocodazole treatment,
providing independent evidence for the importance of μ2–microtubule association in plasmid-based rescue. In two separate cases, the results
revealed functional differences between virus- and plasmid-derived μ2. Ala substitutions within the NTP-binding motif of T1L μ2 also abrogated
its rescue capacity, suggesting that the NTPase or RTPase activity of μ2 is additionally required for effective viral growth.
© 2007 Elsevier Inc. All rights reserved.Keywords: Microtubule; NTPase; Reovirus; Reoviridae; siRNAIntroduction
Mammalian orthoreoviruses (reoviruses) are nonenveloped
dsRNA viruses of the family Reoviridae. Although generally
mild in humans, reovirus infections of lab rodents can produce a
variety of disease syndromes including hepatitis, pneumonitis,
myocarditis, and encephalitis (for review, see Tyler et al., 2001).⁎ Corresponding author. Department of Microbiology and Molecular
Genetics, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115,
USA. Fax: +1 617 738 7664.
E-mail address: mnibert@hms.harvard.edu (M.L. Nibert).
0042-6822/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2007.03.037As a result, reovirus has provided a number of useful models for
studies of viral pathogenesis and is helping to address how
viruses interact with the small intestine, liver, lungs, heart, and
central nervous system of infected hosts. Recently, reovirus has
shown promise as an oncolytic agent (for review, see
Shmulevitz et al., 2005).
The reovirus genome comprises ∼23,500 bp in ten dsRNA
segments, the plus strands of which encode 11 or 12 primary
translation products (for reviews of this and the following
statements, see Coombs, 2006; Guglielmi et al., 2006; Nibert
and Schiff, 2001). Within the infectious virion, the genome
segments are encased by a double-layered protein capsid.
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conformational changes to yield a subvirion particle called the
core, which enters the host cytoplasm and mediates primary
transcription, 5′-capping, and export of the viral plus-strand
RNAs. These primary transcripts consecutively or alternatively
serve as mRNAs for viral protein translation and templates for
minus-strand synthesis to regenerate the dsRNA genome
segments inside newly forming particles. Some of these
newly formed particles can mediate secondary transcription,
substantially amplifying the levels of the plus-strand RNAs and
their encoded proteins (for review, see Zarbl and Millward,
1983). Replication of genome and assembly of new particles are
thought to occur in association with cytoplasmic inclusions in
infected cells, often called viral factories. The complex nature of
these factories and their functions are subjects of ongoing
investigations (Becker et al., 2001, 2003; Broering et al., 2002,
2004, 2005; Mbisa et al., 2000; Miller et al., 2003, 2004; Parker
et al., 2002).
One of the least well understood of the reovirus proteins is
μ2, an 83-kDa protein present in low copy number (20 to 24)
in the viral core (Coombs, 1998; Mustoe et al., 1978). In vitro,
purified μ2 demonstrates both NTPase and RTPase activities
(Kim et al., 2004), and genetic evidence suggests that it may
mediate one or both of these activities inside core particles
(Noble and Nibert, 1997). Ala substitutions for Lys415 and
Lys419 eliminate these activities of purified μ2 (Kim et al.,
2004). A temperature-sensitive reovirus mutant with a lesion
in the M1 genome segment encoding μ2 fails to synthesize
dsRNA at nonpermissive temperature, suggesting that μ2 may
have a role in the viral replicase complex (Coombs, 1996).
Reassortant studies have further suggested that μ2 determines
viral strain differences in core transcriptase activities (Yin et
al., 1996). The μ2 protein binds both ssRNA and dsRNA in
vitro (Brentano et al., 1998). In addition, μ2 binds to cellular
microtubules (Kim et al., 2004) and determines strain
differences in the anchoring of viral factories to microtubules
in infected cells (Parker et al., 2002; Yin et al., 2004).
Although there are nine amino acid differences between the μ2
proteins of our lab's viral clones of reovirus strains T1L and
T3D (Parker et al., 2002), previous studies have shown that
the extent of microtubule association is specifically deter-
mined by the presence of Pro versus Ser at μ2 residue 208,
with Ser208 as in T3D μ2 determining poorer microtubule
association (Miller et al., 2004; Parker et al., 2002; Yin et al.,
2004). Ser208 also makes the μ2 protein more prone to
temperature-dependent aggregation and polyubiquitination,
consistent with a folding defect (Miller et al., 2004). In
anchoring the factories to microtubules, μ2 appears to act
through its association with viral factory matrix protein μNS
(Broering et al., 2002). Other studies have shown that μ2 is a
determinant of strain differences in plaque size (Moody and
Joklik, 1989), rate of viral factory formation (Mbisa et al.,
2000), and sensitivity to mycophenolic acid (Hermann and
Coombs, 2004), and that it also has a role in influencing viral
growth and cytopathology in both cultured cells and newborn
mice (Haller et al., 1995; Matoba et al., 1991, 1993; Sherry and
Blum, 1994; Sherry et al., 1989, 1998).siRNAs and other silencing technologies have become
powerful tools for investigating mammalian RNA and protein
functions (for reviews, see Cejka et al., 2006; Mello and Conte,
2004; Sledz and Williams, 2005). They have also been used to
study many viruses, including the Reoviridae family member
rotavirus (Campagna et al., 2005; Cuadras et al., 2006; Dector et
al., 2002; Lopez et al., 2005;Montero et al., 2006; Silvestri et al.,
2004; Taraporewala et al., 2006). Of particular note is a recent
rotavirus study by Taraporewala et al. (2006) combining siRNA-
based knockdown of the rotavirus NSP2 protein with plasmid-
based rescue of NSP2 expression to provide a new genetic
system for studies of NSP2 functions in infected cells. We
therefore expected that we could also utilize siRNAs to study the
functions of the reovirus μ2 protein in infected cells. In fact, we
would hope to extend this technology to any or all of the reovirus
proteins. Towards this end, for the current study, we performed
experiments using an siRNA directed against theM1 plus-strand
RNA encoding the μ2 protein to suppress both μ2 expression
and viral growth, coupled with plasmids encoding different
forms of μ2 for mediating rescue of these defects. The results
presented below indicate that this is indeed a useful approach for
genetic studies of reovirus proteins, particularly as it has
revealed new functional correlations with μ2–microtubule asso-
ciation and differences between virus- and plasmid-derived μ2.
Results
M1-si suppresses μ2 expression by reoviruses T1L and T3D
siRNA M1-si, targeting a shared sequence in the M1 plus-
strand RNAs of our lab's viral clones of reovirus strains T1L
and T3D (Fig. 1a), was obtained from Dharmacon. To evaluate
the effect of M1-si on expression of the M1-encoded μ2 protein
of each strain, CV-1 cells were transfected with siRNA and at
24 h post-transfection (p.t.) were infected with either T1L or
T3D reovirus at 10 PFU/cell. The cells were incubated for an
additional 0, 24, or 48 h post-infection (p.i.) before harvest, and
cell-associated proteins were prepared for sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) and
immunoblotting. The blots revealed that M1-si suppressed μ2
expression to near the detection limit for both T1L (Fig. 1b) and
T3D (Fig. 1c) reovirus, whereas a nonspecific control siRNA,
also obtained from Dharmacon, had little effect on either virus
(Figs. 1b, c). Analysis of cellular GAPDH levels suggested that
there was similar loading of proteins from each sample (Figs.
1b, c). The lack of effect of the control siRNA provided initial
evidence against the general importance of off-target effects in
the suppression of μ2 expression by M1-si. In repeated
experiments, the reduction in μ2 expression levels by M1-si
was estimated to be ≥90–95% (data not shown, but see Figs.
5g, 7c, and 8d).
M1-si limits expression of other proteins, expansion of
factories, and synthesis of genome
To explore the steps in reovirus infection at which the
suppression of μ2 expression by M1-si may have subsequent
Fig. 1. Effect of siRNA (M1-si) targeting a shared sequence in the M1 plus-strand RNAs of reovirus strains T1L and T3D on μ2 expression levels. (a) The M1
genome sequence of T1L and T3D is shown in the region targeted by M1-si. The M1-si-targeted region is boxed and encompasses nucleotides 1008 to 1026. (b, c)
CV-1 cells were transfected with siRNA and at 24 h p.t. were then infected with T1L (b) or T3D (c) reovirus. The cells were incubated for an additional 0, 24, or
48 h p.i., and cell-associated proteins were prepared for SDS–PAGE and immunoblotting. Protein was detected using specific antibodies against μ2, GAPDH, or
μNS.
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the preceding experiments, we had in fact also analyzed the
samples by immunoblotting for nonstructural protein μNS. In
those samples, we found expression of μNS to be substantially
reduced following M1-si treatment, though still detectable at
both 24 and 48 h p.i. (Figs. 1b, c). In other experiments,
immunoblotting showed that expression of structural proteins
μ1 and λ2 was also greatly reduced following M1-si treatment,
though again still detectable by 24 or 48 h p.i. (data not shown).
To corroborate the immunoblotting results, we additionally
examined cells at 24 h p.i. by immunofluorescence microscopy.
In these experiments, reduced expression of the μ2 and μNS
proteins (Figs. 2a, b), as well as the σNS and λ2 proteins (data
not shown), of strains T1L and T3D was regularly observed
following M1-si treatment. From the combination of blotting
and microscopy results, we estimated that the expression levels
of other viral proteins were reduced by ≥80–90% following
M1-si treatment.
The microscopy approach was further used to evaluate the
viral factories. Expansion of the factories by 24 h p.i. was
greatly limited by M1-si (Figs. 2a, b), consistent with the
reduced expression of not only μ2 but also other viral proteins.
For both T1L and T3D, in the presence of M1-si, the factories
remained small and globular, with the different viral proteins,
though reduced in amounts, continuing to colocalize in these
structures (Figs. 2a, b, and data not shown). In the case of
T1L, the globular morphology of the small factories in M1-si-
treated cells (Fig. 2a, bottom row) contrasted with the
extensively filamentous morphology of the larger T1L
factories formed in the absence of M1-si (Fig. 2a, top row).
The latter morphology is explained by anchoring of the
factories to cellular microtubules through the μ2 protein
(Parker et al., 2002). The appearance of the T1L and T3D
factories at 24 h p.i. following M1-si treatment was similar tothat otherwise seen at earlier times after infection [e.g., at 6 h
p.i. (Parker et al., 2002)].
Separate aliquots of cells from one of the microscopy
experiments with reovirus T3D were also examined by gel
electrophoresis to detect production of the viral dsRNA genome
segments, reflecting minus-strand RNA synthesis coupled to
new particle assembly. Production of the dsRNA segments was
found to be strongly suppressed by M1-si (Fig. 3a), consistent
with a block to multiplication preceding viral genome
synthesis.
Based on these results, we can suggest the following with
regard to the steps in infection at which the suppression of μ2
expression by M1-si may have subsequent effects. As noted in
Introduction, most copies of the reovirus proteins over the
course of an infection are translated from “secondary”
transcripts that are synthesized by viral progeny particles
following dsRNA genome synthesis within these newly formed
particles (Zarbl and Millward, 1983). Thus, the limited
expression of other reovirus proteins in concert with the limited
expansion of the factories and the limited or absent synthesis of
dsRNA genome segments is consistent with a block to infection
by M1-si that precedes genome synthesis and secondary
transcription. Whether “primary” transcription by infecting
particles and translation of proteins from those primary
transcripts are also reduced by M1-si is hard to conclude from
the available data, but the routine detection of other viral protein
expression and small factories may reflect that primary
transcription and translation remain largely intact. Tentatively,
then, we conclude that the block by M1-si follows primary
translation of the viral proteins other than μ2, but precedes
genome synthesis and secondary transcription. This is consis-
tent with evidence from Coombs (1996) concerning the block to
infection at nonpermissive temperature with an M1/μ2
temperature-sensitive mutant.
Fig. 2. Effect of M1-si on expression of μNS and expansion of viral factories for T1L and T3D reoviruses. (a, b) CV-1 cells were transfected with no siRNA or M1-si,
and at 24 h p.t. were then infected with T1L (a) or T3D (b) reovirus at 10 PFU/cell. At 24 h p.i., the cells were fixed and the localization of μ2 and μNS proteins were
examined by immunostaining with specific antibodies to μ2 (directly conjugated to Alexa 488, green channel) and μNS (followed by secondary antibody conjugated to
Alexa 594, red channel). Nuclei were counterstained with DAPI, as seen in the merge images (right column).
304 J. Carvalho et al. / Virology 364 (2007) 301–316M1-si reduces infectious yields of T1L and T3D to differing
extents
To evaluate the effect of M1-si on infectious yields of
reovirus, CV-1 cells were transfected and infected as
described above. The cells were incubated for an additional
0, 24, or 48 h p.i. before harvest, and infectious titers were
determined by plaque assays. M1-si reduced infectious yields
by more than one log10 value at 24 and 48 h for both T1L
and T3D reovirus (Figs. 3b, c; compare bars A and C),
whereas the nonspecific control siRNA had little or no effect
(Fig. 3b, c; compare bars A and B). Interestingly, the yields
of T3D were even more markedly reduced, by more than two
log10 values and essentially to input levels, than were those of
T1L (compare Figs. 3b and c, bar C). This suggests a strain
difference in susceptibility of viral growth to the effect of
M1-si, even though (i) the targeted RNA sequences of T1L
and T3D M1 are identical (see Fig. 1a), (ii) the μ2 expression
levels of both viruses were strongly suppressed by M1-si (see
Figs. 1b, c), and (iii) the expression of other viral proteins andexpansion of the viral factories for both viruses were greatly
limited by M1-si (see Fig. 2). Further experiments were
performed to confirm this strain difference and to identify its
genetic basis.
Reduction in infectious yields by M1-si maps to the T1L and
T3D M1 genome segments
The T1L–T3D strain difference seemed most likely to reflect
an inherent property of the respective M1 genome segments or
their products, which in turn modulated the targeted effect of
M1-si. In that case, the strain difference should map to the M1
segment in a reassortant analysis. To investigate this possibility,
we transfected CV-1 cells with or without M1-si and then
infected the cells with a panel of viruses including T1L and T3D
in addition to T1L-×-T3D reassortants (Brown et al., 1983;
Drayna and Fields, 1982; Nibert et al., 1996). The cells were
incubated for an additional 0 or 48 h p.i. before harvest, and
infectious titers were determined by plaque assays. For each
reassortant, the difference in infectious yields in the presence or
Fig. 3. Effect of M1-si on dsRNA synthesis and infectious viral yields. (a) CV-1 cells were transfected with no siRNA or M1-si, and at 24 h p.t. were then infected with
T3D reovirus at 10 PFU/cell. Cells were incubated for 24 or 48 h p.i., and samples were prepared for gel electrophoresis to detect the viral dsRNA genome segments. L,
genome segments encoding λ proteins; M, genome segments encoding μ proteins; S, genome segments encoding σ proteins. (b, c) CV-1 cells were transfected with no
siRNA, nonspecific control siRNA, or M1-si, and at 24 h p.t. were then infected with T1L (b) or T3D (c) reovirus at 10 PFU/cell. Cells were harvested at 0, 24, or 48 h
p.i., and viral titers were determined by plaque assays. Log10 changes in viral titer relative to time 0 are indicated. Each bar represents the average obtained from three
independent experiments, and error bars indicate the standard deviations.
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ranked by the extent of reduction in yields attributable to M1-
si (Table 1). M1-si reduced infectious yields for those
reassortants with the T3D M1 segment to a consistently
greater extent than for those reassortants with the T1L M1
segment, and a statistical analysis of the data [Mann–Whitney
test (Bodkin and Fields, 1989; Sherry et al., 1989; Zar, 1984)]
revealed that origin of the M1 segment, and only the M1
segment, segregated with this phenotype to a significant
degree (M1, p=0.0016; other segments, p>0.05) (Table 1).
These results corroborate the T1L–T3D strain difference and
indicate that this difference reflects an inherent property of
the respective M1 segments or their products. As a
consequence, they represent further evidence that the primary
effect of M1-si is targeted to the M1 RNA. As noted in
Introduction, the M1-encoded μ2 proteins of our lab's T1L
and T3D viral clones differ by nine amino acids including
Pro/Ser208, which determines the relative capabilities for
better (Pro208, T1L) versus poorer (Ser208, T3D) micro-
tubule association, the latter accompanied by increased
aggregation and polyubiquitination of μ2 (Miller et al.,
2004; Parker et al., 2002; Yin et al., 2004). Thus, onepossible explanation for the new strain difference observed in
this study was that the poorer functionality of T3D μ2 made
the T3D virus and T3D-M1-containing reassortants more
sensitive to the effects of reducing μ2 levels by M1-si.
Reduction in infectious yields by M1-si correlates with
difference in microtubule association conferred by Pro/Ser208
Different viral clones of T3D reovirus obtained from other
labs have been shown to differ in their capabilities for
microtubule anchoring of the viral factories, and these
differing capabilities have again been correlated with the
presence of Pro versus Ser at μ2 residue 208 (Parker et al.,
2002; Yin et al., 2004). For example, a T3D viral clone
obtained from the Cashdollar lab (T3DC) has Pro instead of
Ser at μ2 residue 208 and forms extensively microtubule-
anchored factories (Fig. 4a), unlike the T3D viral clone from
our lab (Parker et al., 2002). On the other hand, an
independent viral field isolate, Type 3 clone 12 (T3c12),
has Ser at μ2 residue 208 and does not form extensively
microtubule-anchored factories (Fig. 4a) (Yin et al., 2004).
Notably, both T3DC and T3c12 are identical to T1L and T3D
Table 1
Genetic analysis of M1-si-induced reduction in infectious viral yield by using T1L×T3D reassortant viruses
Virus
strain a
Genotype b Log10 difference in
yields between±siRNA
groups at 48 h c
L1 L2 L3 M1 M2 M3 S1 S2 S3 S4
EB144 L L L L D D L L D L 0.50±0.24
EB39 L D D L D D D D D D 0.70±0.19
EB87 L D L L D L L D L L 0.73±0.19
EB143 D L L L L L D L L L 0.86±0.51
H24 L L L L L L L L L D 1.04±0.11
EB140 D D L L L L L L D L 1.04±0.61
H14 L L D L L L L D D L 1.10±0.43
T1L L L L L L L L L L L 1.77±0.39
EB113 L L L D L L L L D L 1.93±0.25
EB146 L L L D L L L L L D 1.97±0.12
EB108 L D L D L L L L D D 2.20±0.20
G16 L L L D L L L D L L 2.70±0.34
T3D D D D D D D D D D D 3.52±0.27
P values d 0.87 0.99 0.94 0.0016 0.20 0.47 0.81 0.83 0.99 0.38
a Reassortants are described in Materials and methods. Strains are listed in order of increasing difference in infectious yield between M1-si-treated and non-treated
samples.
b Parental origins of genome segments are indicated: D, T3D; L, T1L.
c Mean±standard deviation of three determinations each.
d Two-tailed significance values from the Mann–Whitney test performed using Instat Version 3 (Graph Pad).
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(data not shown). Upon testing T3DC and T3c12 for the
effects of M1-si on viral growth as in the preceding sections,
we found that T3DC behaved similarly to T1L, with
infectious yields reduced by less than two log10 values at
24 and 48 h p.i., whereas T3c12 behaved similarly to our
lab's viral clone of T3D, with infectious yields reduced by
more than two log10 values, and essentially to input levels, at
24 and 48 h p.i. (Fig. 4b, compare bars C and D). These
results are therefore consistent with the conclusion that the
strain differences in growth reduction by M1-si are correlated
with the other differing properties of μ2, including micro-
tubule association, conferred by the sequence polymorphism
Pro/Ser208. Further genetic tests would be useful to confirm
this conclusion, but were beyond the scope of this study.
Reduction of infectious yields by M1-si is rescued by
plasmid-encoding T1L but not T3D μ2
Previous studies with rotavirus have provided evidence
that the viral plus-strand RNA molecules that serve for
replication and packaging into progeny particles are largely
resistant to siRNA-based restriction (Dector et al., 2002;
Silvestri et al., 2004; Taraporewala et al., 2006). The
reduction in infectious yields of rotavirus is thereby largely
attributable to the reduction in protein expression from the
viral plus-strand RNA molecules that serve for translation
(i.e., those that serve as mRNAs) and are sensitive to siRNA-
based restriction. As a consequence, if the viral protein whose
expression is reduced by siRNA-based restriction can be
effectively supplied in trans, then yields of infectious progeny
can be rescued to some degree (Taraporewala et al., 2006).
Given many similarities in the basic replication strategies ofrotavirus and reovirus, both members of the family Reoviri-
dae, we hypothesized that this same mechanism of siRNA-
based reduction of infectious yields may hold true for
reovirus.
To test this hypothesis, we constructed rescue plasmids to
express the sequence-matched μ2 proteins of our lab's viral
clones of strains T1L and T3D, but including three silent
(wobble [WO]) mutations in the RNA sequence targeted by
M1-si in each M1 gene (Fig. 5a; WO mutations shown by
asterisks). When transfected into CV-1 cells, these plasmids
expressed the respective μ2 proteins to similarly high levels as
did previously described plasmids (Parker et al., 2002)
containing the fully wild-type (WT) M1 genes of these strains
(i.e., again sequence-matched at the amino acid level for each
respective strain, but without the WO mutations in the genes)
(Fig. 5b).
To test for rescue of infectious yields, CV-1 cells were
transfected with (i) either of the plasmids alone, (ii) M1-si alone,
or (iii) either plasmid in combination with M1-si. Cotransfec-
tions of M1-si with either M1(T1L)WT or M1(T3D)WT were
included as controls. At 24 h p.t., the cells were then infected
with either T1L or T3D reovirus at 10 PFU/cell. The cells were
incubated for an additional 0, 24, or 48 h p.i. before harvest, and
infectious titers were determined by plaque assays. In initial
trials, we matched the transfected plasmids (encoding T1L or
T3D μ2) to the infecting virus (T1L or T3D), but in subsequent
trials we tested each plasmid with the opposite virus as
explained below. In these experiments, infectious yields from
cells transfected with either of the plasmids alone were mostly
similar to those from mock-transfected cells (Figs. 5c–f,
compare bars A and B; greatest difference seen in panel c),
suggesting that the plasmids and their products were not
strongly toxic. Also, reproducing preceding results (see Figs.
Fig. 4. Effect of M1-si on infectious viral yields of T3DC and T3c12 reoviruses.
(a) Protein sequences for μ2 from reovirus strains T1L, T3D, T3DC, and T3c12.
T1L and T3DC reoviruses have a Pro at μ2 residue 208 and encode μ2 proteins
that strongly associate with microtubules (+); T3D and T3c12 reoviruses have a
Ser at this position and encode a μ2 protein that weakly associates with
microtubules (−). (b) CV-1 cells were transfected with no siRNA or M1-si, and
at 24 h p.t. were then infected with T3DC or T3c12 reovirus at 10 PFU/cell. Cells
were harvested at 0, 24, or 48 h p.i., and viral titers were determined by plaque
assays. Log10 changes in viral titer relative to time 0 are indicated. Each bar
represents the average obtained from three independent experiments, and error
bars indicate the standard deviations.
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were reduced by substantial, though differing, extents for both
T1L and T3D reovirus (Figs. 5c–f, bar C).
The results for combined transfections with rescue plasmid
and M1-si were as follows. Plasmid M1(T1L)WO provided
∼10-fold rescue of T1L yields by 48 h p.i. (Fig. 5c; compare
bars C and D). In contrast, plasmid M1(T3D)WO provided less
than 10-fold rescue of T3D yields at either 24 or 48 h p.i (Fig.
5d, compare bars C and D). Moreover, as expected, plasmids
M1(T1L)WT and M1(T3D)WT (both still targeted by M1-si)
provided less than 10-fold rescue of either T1L or T3D yields in
the respective cases (Figs. 5c, d; compare bars C and E).
Together, these initial results suggest either a defect in the
capacity of plasmid-derived T3D μ2 to provide rescue in this
system or a defect in the capacity of T3D virus to be rescued. To
distinguish between these possibilities, we tested the capacity of
plasmid-encoding T1L μ2 to rescue T3D yields and the capacity
of plasmid-encoding T3D μ2 to rescue T1L yields. In the first
case, we found that plasmid M1(T1L)WO provided greater than
100-fold rescue of T3D yields by 48 h p.i. (Fig. 5e, compare
bars C and D). Interestingly, plasmid T1L(M1)WT provided
greater than 10-fold rescue of T3D yields by 48 h p.i. (Fig. 5e,
compare bars C and E). In contrast, we found that neither
plasmid M1(T3D)WO (Fig. 5f, compare bars C and D) nor
plasmid M1(T3D)WT (Fig. 5f, compare bars C and E) provided
as much as 10-fold rescue of T1L yields at either 24 or 48 h p.i.Following SDS–PAGE of samples collected in parallel with
those for plaque assays, immunoblot analysis revealed that M1-
si strongly suppressed expression of μ2 in these experiments, as
expected from preceding results (see Figs. 1b, c), and that the
WO, but not the corresponding WT, plasmids strongly
counteracted this expression defect (Fig. 5g, and data not
shown). We conclude from these results that the difference in
rescue between T1L and T3D in the first experiments with
strain-matched virus and plasmid (see Figs. 5c, d) was based in
the plasmid, not the virus. We furthermore conclude that
plasmid-derived T3D μ2 has a largely post-expression defect in
its capacity to rescue viral growth following reduction by M1-si.
The latter conclusion presents an interesting paradox, in that
virus-derived T3D μ2 is functional to support the growth of
T3D virus and T3D-M1-containing reassortants, whereas
sequence-matched, plasmid-derived T3D μ2 is much less or
not so functional in the rescue system.
Strain difference in rescue by plasmid-derived μ2 is primarily
determined by Pro/Ser208
As noted above, a previous study has identified nine amino
acid differences between the μ2 proteins of our lab's viral
clones of strains T1L and T3D (Parker et al., 2002). Any one of
these nine differences might be responsible for the different
capacities of the sequence-matched, plasmid-derived T1L and
T3D μ2 proteins to rescue viral growth after M1-si treatment.
The difference at μ2 residue 208 (Fig. 6a) is noteworthy,
however, because it determines the relative capability of μ2 to
associate with microtubules and, reciprocally, its relative
proneness to undergo aggregation and polyubiquitination
(Miller et al., 2004; Parker et al., 2002; Yin et al., 2004). We
therefore hypothesized that Pro/Ser208 may be the primary
determinant of whether plasmid-derived μ2 is competent for
rescue of infectious yields in this system.
To test the importance of Pro/Ser208 within the rescuing μ2
protein, we constructed plasmids that not only contained the
previously utilized WO mutations in the M1-si-targeted
sequence of each M1 gene (see Fig. 5a) but also encoded the
reciprocal amino acids at position 208: Pro208 changed to Ser in
the otherwise T1L μ2 background [T1L(P208S)] and Ser208
changed to Pro in the otherwise T3D μ2 background [T3D
(S208P)]. Both of these new plasmids provided similarly high
levels of μ2 protein expression following transfection of CV-1
cells (Fig. 6b). To test for rescue of infectious yields, CV-1 cells
were transfected with (i) either of the new plasmids alone, (ii)
M1-si alone, or (iii) either new plasmid in combination withM1-
si. Cotransfections of M1-si with M1(T1L)WOwere included as
controls. At 24 h p.t., the cells were then infected with T3D
reovirus at 10 PFU/cell. The cells were incubated for an
additional 0, 24, or 48 h p.i. before harvesting, and infectious
titers were determined by plaque assays. In these experiments,
infectious yields from cells transfected with the new rescue
plasmids alone were similar to those frommock-transfected cells
(Figs. 6c, d; compare bars A and B). Also, as expected from
preceding results, infectious yields of T3D from cells transfected
with M1-si alone were substantially reduced (Figs. 6c, d; bar C).
Fig. 5. Effect of plasmid-based expression of T1L and T3D μ2 on M1-si-based reduction of infectious viral yields. (a) Sequence of rescue plasmid encoding T1L and
T3DM1 in the region targeted by M1-si. Asterisks indicate the nucleotides that were changed to encode silent (wobble) mutations. (b) CV-1 cells were transfected with
5 μg of either pCI-M1(T1L) or pCI-M1(T3D) rescue plasmids. In each case, these plasmids either contained wobble mutations in the M1-si-targeted sequence
(designated as WO plasmids) or did not (designated as WT plasmids). The cells were incubated for an additional 24 h p.i., and cell-associated proteins were prepared
for SDS–PAGE and immunoblotting. Protein was detected using specific antibodies against μ2. (c, d, e, f) CV-1 cells were transfected with no siRNA, M1-si, or M1-si
in combination with a particular rescue plasmid, and at 24 h p.t. were then infected with T1L (c, f) or T3D (d, e) reovirus at 10 PFU/cell. Cells were harvested at 0, 24,
or 48 h p.i., and viral titers were determined by plaque assays. Log10 changes in viral titer relative to time 0 are indicated. Each bar represents the average obtained from
three independent experiments, and error bars indicate the standard deviations. (g) CV-1 cells were transfected with no siRNA, M1-si, or M1-si in combination with
either M1(T1L)WTor M1(T1L)WO plasmid, and at 24 h p.t. were then infected with T3D reovirus. The cells were incubated for an additional 0, 24, or 48 h p.i., and
cell-associated proteins were prepared for SDS–PAGE and immunoblotting. Protein was detected using specific antibodies against μ2 or GAPDH.
308 J. Carvalho et al. / Virology 364 (2007) 301–316The results for combined transfections with rescue plasmid
and M1-si were as follows. Whereas plasmid M1(T1L)WO
provided greater than 100-fold rescue of T3D yields by 48 h p.i.
(Fig. 6c, compare bars C and D), plasmid M1(T1L,P208S)WO
provided less than 10-fold rescue of T3D yields by either timepoint (Fig. 6c, compare bars C and E). On the other hand,
plasmid M1(T3D,S208P)WO provided ∼100-fold rescue of
T3D yields by 48 h p.i. (Fig. 6d, compare bars C and E), very
similar to that provided by plasmid M1(T1L)WO (Fig. 6d,
compare bars C and D). In yet another experiment, we found
Fig. 6. Effect of μ2 amino acid Pro/Ser208 on complementation of M1-si-based
reduction of infectious viral yields. (a) Protein sequences for μ2 from reovirus
strains T1L or T3D, or plasmids encoding T1L(P208S) or T3D(S208P) μ2. Box
indicates the position of amino acid 208. T1L reovirus and plasmid encoding
T3D(S208P) μ2 have a Pro at this position and encode a μ2 protein capable of
strongly associating with microtubules (+); T3D reovirus and plasmid encoding
T1L(P208S) μ2 have a Ser substituted at this position and weakly associate with
microtubules (−). (b) CV-1 cells were transfected with 5 μg of either M1(T1L,
P208S)WO or M1(T3D,S208P)WO rescue plasmids. The cells were incubated
for an additional 24 h p.i., and cell-associated proteins were prepared for SDS–
PAGE and immunoblotting. Protein was detected using specific antibodies
against protein μ2. (c, d) CV-1 cells were transfected with no siRNA, rescue
plasmid alone, M1-si alone, or M1-si in combination with a particular rescue
plasmid, and at 24 h p.t. were infected with T3D reovirus at 10 PFU/cell. Cells
were harvested at 0, 24, or 48 h p.i., and viral titers were determined by plaque
assays. Log10 changes in viral titer relative to time 0 are indicated. Each bar
represents the average obtained from three independent experiments, and error
bars indicate the standard deviations.
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rescue of T1L yields by 48 h p.i., very similar to that provided
by plasmid M1(T1L)WO (data not shown). These results
obtained after swapping Pro/Ser208 into the opposite μ2
backgrounds suggest that the other eight amino acid differences
between T1L and T3D μ2 play little if any role in the observed
strain difference in rescue. We therefore conclude that the strain
difference in capacity of plasmid-derived T1L and T3D μ2 to
rescue the M1-si-based reduction of infectious yields is
determined primarily by the Pro/Ser difference at residue 208.
Rescue by plasmid-based μ2 expression is
microtubule-dependent
Because Pro (T1L) versus Ser (T3D) at μ2 position 208
determines the relative capability of μ2 to associate with
microtubules (T1L associates better than T3D) (Miller et al.,
2004; Parker et al., 2002; Yin et al., 2004), one possible
explanation for the difference in rescue capacity of T1L and
T3D μ2 in the preceding experiments was that rescue is
microtubule-dependent. In other words, T1L μ2 may be better at
rescuing viral growth because it is better at associating with
microtubules. As a test of this possibility, we performed rescue
experiments with T1L μ2 in the presence or absence of the
microtubule-depolymerizing drug nocodazole.
CV-1 cells were transfected with (i) M1-si alone or (ii)
rescue plasmid M1(T1L)WO in combination with M1-si, and
at 24 h p.t., the cells were infected with either T1L or T3D
reovirus at 10 PFU/cell. The cells were incubated for an
additional 0, 24, or 48 h p.i. before harvesting, and infectious
titers were determined by plaque assays. In addition, to one
replicate of each sample destined for harvest at 24 or 48 h p.i.,
10 μM nocodazole was added for the remainder of the growth
period beginning at 6 h p.i. In these experiments, nocodazole
treatment had little if any effect on infectious yields from
mock-transfected cells infected with either T1L or T3D
reovirus (Figs. 7a, b; compare bars A and B), consistent
with previous results involving colchicine (another micro-
tubule-depolymerizing drug) or nocodazole treatments (Dales,
1963; Spendlove et al., 1964) (J. S. L. Parker and M. L.
Nibert, unpublished data). Similarly, nocodazole treatment had
little if any additive effect on the reduction of infectious yields
provided by transfection with M1-si alone, in the setting of
either T1L or T3D infection (Figs. 7a, b; compare bars C and
D). In striking contrast, however, nocodazole treatment
markedly inhibited the rescue of infectious yields provided
by cotransfection with plasmid M1(T1L)WO, in the setting of
either T1L or T3D infection (Figs. 7a, b; compare bars D–F).
Following SDS–PAGE of samples collected in parallel with
those for plaque assays at the 0 and 48 h p.i. time points,
immunoblot analysis revealed that treatment with nocodazole
had little or no effect on the expression levels of T1L μ2 (Fig.
7c), thus indicating that the lack of rescue of infectious yields
by plasmid-derived T1L μ2 in these experiments was not
because of a μ2 expression defect attributable to nocodazole.
We conclude from these results that the rescue of infectious
yields by plasmid-derived T1L μ2 is strongly microtubule-
Fig. 7. Effect of nocodazole on complementation of M1-si-based reduction of
infectious viral yields. (a, b) CV-1 cells were transfected with no siRNA, M1-si,
or M1-si in combination with M1(T1L)WO plasmid, and at 24 h p.t. were
infected with T1L (a) or T3D (b) reovirus at 10 PFU/cell. At 6 h p.i., a subset of
the infected cells were treated with 10 μM nocodazole and incubated further.
Cells were harvested at 0, 24, or 48 h p.i., and viral titers were determined by
plaque assays. Log10 changes in viral titer relative to time 0 are indicated. Each
bar represents the average obtained from three independent experiments, and
error bars indicate the standard deviations. (c) CV-1 cells were transfected with
no siRNA, M1-si, or M1-si in combination with M1(T1L)WO plasmid, and at
24 h p.t. were infected with T3D reovirus at 10 PFU/cell. At 6 h p.i., a subset of
the infected cells were treated with 10 μM nocodazole and incubated further.
Samples were harvested at 0 and 48 h p.i., and cell-associated proteins were
prepared for SDS–PAGE and immunoblotting. Protein was detected using
specific antibodies against μ2 or GAPDH.
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presents another interesting paradox, in that virus-derived T1L
μ2 is functional to support approximately normal growth of
T1L virus in the presence of nocodazole whereas sequence-
matched, plasmid-derived T1L μ2 is much less or not so
functional in the rescue system. We furthermore infer from
these results that the poor capacity of T3D μ2 to providerescue in preceding experiments may be explained at least in
part by its reduced capability to associate with microtubules.
Further test of the rescue system: importance of μ2 NTPase or
RTPase function
The capacity of plasmid-based expression of T1L μ2 to
rescue infection after M1-si-based reduction of infectious yields
provides a general genetic approach by which sequence
determinants of μ2 functions that are required for productive
infection can be identified or confirmed. The preceding
experiments involving plasmid-based expression of T1L,
T3D, T1L(P208S), and T3D(S208P) μ2 exemplify this
application. To provide further evidence for the utility of this
approach, we used it to test the relevance of μ2 NTPase or
RTPase function during reovirus infection. Previous studies
have implicated μ2 protein in influencing in vitro enzymatic
activities of reovirus core particles (Noble and Nibert, 1997; Yin
et al., 1996). Results from our lab have further shown that
purified μ2 possesses in vitro NTPase and RTPase activities
(Kim et al., 2004), which have been mapped in part to the Lys
residues at positions 415 and 419, within a putative NTP-
binding motif of μ2 (Nibert and Kim, 2004; Noble and Nibert,
1997) (Fig. 8a). When these residues are mutated to Ala (Fig.
8a, asterisks), the in vitro NTPase and RTPase activities of μ2
[i.e., μ2(K415,419A)] are abrogated (Kim et al., 2004).
To address the importance of μ2 NTPase or RTPase function
during reovirus infection, we incorporated changes encoding
the Ala substitutions at residues 415 and 419 into the M1(T1L)
WO plasmid [to produce M1(T1L,K415/419A)WO] and then
tested its capacity to rescue the M1-si-based reduction of
infectious yields. When transfected into CV-1 cells, this new
plasmid expressed the μ2 protein to similarly high levels as M1
(T1L)WO (Fig. 8b). To test for rescue of infectious yields, CV-1
cells were transfected with (i) M1(T1L,K415/419A)WO
plasmid alone, (ii) M1-si alone, or (iii) either M1(T1L)WO or
M1(T1L,K415/419A)WO plasmid in combination with M1-si.
At 24 h p.t., the cells were then infected with T3D reovirus at
10 PFU/cell. The cells were incubated for an additional 0, 24, or
48 h p.i. before harvesting, and infectious titers were determined
by plaque assays. In these experiments, infectious yields from
cells transfected with the M1(T1L,K415/419A)WO alone were
similar to those from mock-transfected cells (Fig. 8c, compare
bars A and B). Also, as expected from preceding results,
infectious yields of T3D from cells transfected with M1-si alone
were substantially reduced (Fig. 8c, bar C). The results for
combined transfections with rescue plasmid and M1-si were as
follows. Whereas plasmid M1(T1L)WO provided greater than
10-fold rescue of T3D infection by 48 h p.i. (Fig. 8c, compare
bars C and D), plasmid M1(T1L,K415/419A)WO provided less
than 10-fold of T3D infection by either time point (Fig. 8c, bar
E). Following SDS–PAGE of samples collected in parallel with
those for plaque assays, immunoblot analysis revealed that M1-
si strongly suppressed expression of T3D μ2 in these
experiments (Fig. 8d), as expected from preceding results, and
that both rescue plasmids counteracted this expression defect
(Fig. 8d). We conclude from these results that the NTPase or
Fig. 8. Effect of NTPase or RTPase function of μ2 protein on complementation of M1-si-based reduction of infectious viral yields. (a) Putative NTP-binding motifs in
the T1L μ2 protein are shown. Asterisks indicate the two Ala-for-Lys substitutions in the mutant μ2 protein K415/419A. (b) CV-1 cells were transfected with 5 μg of
M1(T1L)WO or M1(T1L,K415/419A)WO plasmid. Samples were harvested at 24 h p.i., and cell-associated protein was prepared for SDS–PAGE and
immunoblotting. Protein was detected using specific antibodies against μ2. (c) CV-1 cells were transfected with no siRNA, M1(T1L,K415/419A)WO rescue plasmid,
M1-si alone, M1-si plus M1(T1L)WO rescue plasmid, or M1-si plus M1(T1L,K415/419A)WO rescue plasmid, and at 24 h p.t. were infected with T3D reovirus at
10 PFU/cell. Cells were harvested at 0, 24, or 48 h p.i., and viral titers were determined by plaque assays. Log10 changes in viral titer relative to time 0 are indicated.
Each bar represents the average obtained from three independent experiments, and error bars indicate the standard deviations. (d) CV-1 cells were transfected with no
siRNA, M1-si, or M1-si in combination with M1(T1L)WO plasmid or M1(T1L,K415/419A)WO plasmid, and at 24 h p.t. were then infected with T3D reovirus. The
cells were incubated for an additional 0, 24, or 48 h p.i., and cell-associated proteins were prepared for SDS–PAGE and immunoblotting. Protein was detected using
specific antibodies against μ2 or GAPDH.
311J. Carvalho et al. / Virology 364 (2007) 301–316RTPase function of μ2 protein newly synthesized during the
course of infection is required for effective viral growth.
Discussion
siRNAs and other silencing technologies have become
powerful tools for investigating RNA and protein functions in
many organisms and viruses. In this study, we applied this
approach to reovirus, specifically to its M1 plus-strand RNA
and encoded μ2 protein, during productive infections in CV-1
cells. We targeted μ2 because it is one of the least wellunderstood of the reovirus structural proteins and to which we
have devoted a good deal of effort in trying to decipher its
functions. For example, the microtubule-anchoring activity of
μ2 has been established (Kim et al., 2004; Miller et al., 2004;
Parker et al., 2002; Yin et al., 2004), but its significance for
infection has remained unclear. The NTPase and RTPase
activities of purified μ2 and the role of M1/μ2 in genetically
influencing enzymatic activities of reovirus core particles have
also been established, but only in vitro (Kim et al., 2004; Noble
and Nibert, 1997; Yin et al., 1996); their significance for
infection has remained unproven. We were therefore eager to
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protein-based rescue, as a potential means for advancing our
understanding of μ2 functions during reovirus infection.
It is worth emphasizing that the approach described here for
rescue of infectious yields might not have worked. If the M1
plus-strand RNAs that are used for replication and packaging
into infectious progeny had also been susceptible to siRNA-
based degradation, then to rescue infectious yields, we would
have needed to replace those molecules as well as the M1 plus-
strand RNAs that are used for μ2 translation. Instead, by
needing to replace only the latter, we were able to use a common
expression plasmid (pCI-neo) for M1 mRNA and μ2 protein,
without any effort for the RNA to be properly terminated for use
in replication and packaging. Thus, our success at rescuing
infectious yields by this approach provides strong evidence, as
previously indicated for rotavirus (Dector et al., 2002; Silvestri
et al., 2004; Taraporewala et al., 2006), that the reovirus plus-
strand RNA molecules that are used for replication and
packaging into infectious progeny are much less susceptible
to silencing than are the mRNAs.
The difference in susceptibility of T1L and T3D reovirus to
reduction of infectious yields by M1-si, despite sharing the
same target sequence, was unexpected but explainable. We
propose that μ2 is one of the reovirus proteins for which a
relatively low level of expression may be sufficient for
supporting production of infectious progeny. We further
propose that the levels of functional μ2 are in greater excess
in T1L infection than in T3D infection, as reflected by the
reduced microtubule association of T3D μ2 as well as by its
greater tendency to undergo aggregation and polyubiquitination
(Miller et al., 2004; Parker et al., 2002; Yin et al., 2004). As a
result, in the setting of T3D infection, we propose that it is easier
to reduce μ2 expression to levels that provide greater reduction
of infectious yields. The same holds true for infections with
T3D-M1-containing reassortants and T3c12. This interpretation
may also help to explain why plasmid M1(T1L)WT, which
remains targeted by M1-si, can support some rescue of
infectious yields in certain cases. The idea would be that even
the small amount of μ2 expression from this plasmid that may
evade silencing would be enough to support a demonstrable
increase in viral growth.
Previous results (Dales, 1963; Spendlove et al., 1964) (J. S. L.
Parker and M. L. Nibert, unpublished data), reproduced in this
study, have shown that the microtubule-depolymerizing drug
nocodazole causes little reduction in infectious yields under
normal circumstances of reovirus growth in culture. This is true
both for a strain such as our lab's viral clone of T3D, whose μ2
protein shows poor association with microtubules, and for a
strain such as T1L, whose μ2 protein shows better association
with microtubules (Miller et al., 2004; Parker et al., 2002; Yin
et al., 2004). Thus, to date, there has been no strong evidence
that μ2–microtubule association has a significance for infec-
tious yields of reovirus in culture. Then how can we explain the
nocodazole results in this report showing that, in the setting of
plasmid-based rescue of T1L μ2 expression in CV-1 cells, intact
microtubules are required for reovirus growth and production of
infectious progeny? A possible explanation is that in thecircumstance of T1L μ2 expression from plasmid-derived
mRNAs, microtubule binding of μ2 is needed to ensure that μ2
can be properly folded and/or can reach the proper sites for viral
replication and assembly. This would suggest in turn that T1L
μ2 expression from virus-derived transcripts may be more
specifically localized, in closer juxtaposition to the expression
sites for other viral proteins that may assist μ2 folding and/or to
the proper sites for viral replication and assembly, such that
microtubule association of μ2 is not as strictly required. This
explanation leaves open the question of what role μ2–
microtubule association may have under the normal circum-
stance of μ2 expression from virus-derived transcripts, but we
recognize that this role may be more evident in host tissues,
such as for infection of certain cell types or spread between
cells. In any case, this study provides the first example in which
intact microtubules are required for μ2 function in reovirus
replication.
In light of the preceding explanation for the nocadozole
effect, it is possible that plasmid-derived T3D μ2 was poor at
rescue of infectious yields after M1-si treatment because of its
poor microtubule association capability. This explanation is
consistent with the importance of Pro208, as in T1L and T3D
(S208P) μ2, in supporting strong rescue of infectious yields.
However, Ser208 as in T3D and T1L(P208S) μ2 is not only
associated with poor microtubule association (Miller et al.,
2004; Parker et al., 2002; Yin et al., 2004) and poor rescue (this
study), but also with a proneness of μ2 to aggregation and
polyubiquitination (Miller et al., 2004). Thus, it is also possible
that plasmid-derived T3D μ2 was poor at rescue of infectious
yields because less of it remains available in functional form
after expression. It seems necessary to separate, if possible, the
microtubule-binding and aggregation phenotypes of μ2 in order
to answer this question more definitively. In any case, the results
for T3D μ2 reveal another difference between virus- and
plasmid-derived protein, in this case in the absence of
nocodazole, in that virus-derived T3D μ2 is functional to
support viral growth but plasmid-derived T3D μ2 is not so
functional in the rescue system. As in the preceding paragraph, a
possible explanation is that expression of μ2 from virus-derived
transcripts may be more specifically localized, in closer
juxtaposition to the expression sites for other viral proteins
that may assist μ2 folding and/or to the proper sites for viral
replication and assembly, such that the defects of virus-derived
T3D μ2 are blunted.
The failure of plasmid-encoding μ2(K415,419A) to rescue
infectious yields of T3D following reduction with M1-si
represents the first direct evidence that the μ2 NTPase or
RTPase function has significance for infection. Our lab's
previous evidence with regard to these activities of μ2 has been
restricted to in vitro findings (Kim et al., 2004; Noble and
Nibert, 1997), as has been previous evidence from the Coombs
lab implicating μ2 as a determinant of strain differences in the
transcriptase activities of reovirus cores (Yin et al., 1996). In
addition, the Coombs lab has provided in vivo evidence that a
temperature-sensitive form of μ2 is not competent to support the
synthesis of genomic dsRNA at nonpermissive temperature,
implicating μ2 in the assembly or function of viral replicase
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consistent with our tentative conclusion that suppression of μ2
expression by M1-si imposes a block to reovirus infection that
follows primary translation but precedes genome synthesis and
secondary transcription. Combining these results, our working
hypothesis is that, within infected cells, the μ2 protein is
normally assembled into progeny particles, where its NTPase
function is required for genome replication and/or secondary
transcription, as well as for primary transcription once progeny
virions are released and move on to infect new cells. In the case
of transcription, the RTPase activity of μ2 may be instead or
additionally required in 5′-capping of the plus-strand RNAs,
i.e., for generating a diphosphorylated 5′ end on each RNA to
which GMP is then linked by the guanylyltransferase λ2
(Cleveland et al., 1986; Furuichi et al., 1976; Mao and Joklik,
1991). Having successfully applied the siRNA approach, we are
now in stronger position to perform a combination of future
studies in vitro and in vivo to dissect the different roles of μ2
during infection.
As the current report was being finalized for initial
submission, a related one from the Dermody lab was published
(Kobayashi et al., 2006). In this other report, the authors
describe striking new RNA interference results for the reovirus
μ2, μNS, and σNS proteins, and also demonstrate rescue of
infectious yields by plasmid-derived μNS. For μ2-related
experiments that overlap in these two reports, the results are
in strong agreement. The utility of silencing and complementa-
tion for genetic studies of reovirus has thus been established to
date for two of the viral proteins.
Materials and methods
Cells, viruses, antibodies, and enzymes
CV-1 (African green monkey kidney) cells were maintained
in Dulbecco's Modified Eagle Medium (DMEM) (GIBCO)
containing 10% fetal bovine serum (HyClone) and 10 μg/ml of
gentamicin (GIBCO). Mouse L929 cells adapted to spinner
culture were maintained in Joklik's Modified Eagle Medium
(Irvine Scientific) containing 2% fetal bovine serum and 2%
bovine calf serum (HyClone), plus 2 mM L-glutamine, 100 U/
ml penicillin G, and 100 μg/ml streptomycin (Irvine Scientific).
Reovirus strains T1L and T3D were our lab stocks derived from
clones from the B. N. Fields lab. The T3D virus was the same as
that designated T3DN in some other recent reports from our lab.
Third-passage L929 cell lysate stocks of doubly plaque-purified
reovirus clones were used for all infections. Antibodies for
immunoblot detection of μ2 and μNS have been described
(Broering et al., 2000; Parker et al., 2002). Antibody against
GAPDH was from Santa Cruz Biotech. Microscopy studies to
detect μ2 and μNS protein used anti-μ2 antibodies directly
conjugated to Alexa 488 and anti-μNS antibodies followed by
secondary staining with goat anti-rabbit antibodies conjugated
to Alexa 594 (Miller et al., 2003; Parker et al., 2002). All
antibodies were titrated to optimize signal-to-noise ratio. All
enzymes were from New England Biolabs unless otherwise
noted.Rescue plasmids
pCI-M1(T1L) and pCI-M1(T3DN) [designated M1(T1L)WT
and M1(T3D)WT in this report] have been described previously
(Parker et al., 2002) and encode μ2 proteins with the same
amino acid sequences as those of the T1L and T3D reoviruses
from our lab. To obtain point mutations in the M1 gene
encoding μ2, overlap PCR mutagenesis with Pfu polymerase
and the QuikChange XL site-directed mutagenesis kit were
employed (Stratagene). Forward primer (5′-CTTGAAA-
TGTTGGGTATCGAGATCGCCGACTATTGCATTCGTC-3′)
and reverse primer (5′-GACGAATGCAATAGTCGGCGAT-
CTCGATACCCAACATTTCAAG-3′) were used to mutate the
M1 gene by introducing silent mutations (wobble [WO]
cytosines) at nucleotides 112, 118, and 121, at the same time
introducing a new AciI site. AciI digests were then used to
identify the clones that had the proper wobble changes. Positive
candidates were then sequenced to confirm that there were no
additional mutations incorporated during PCR. Positive candi-
dates from sequencing were then digested with EcoRV and
SacII to yield fragments containing the wobble mutations,
which were then subcloned back into M1(T1L)WTor M1(T3D)
WT to produce plasmids pCI-M1(T1L)WO and pCI-M1(T3D)
WO [henceforth designated M1(T1L)WO and M1(T3D)WO in
this report].
pCI-M1(T1L)-P208S and pCI-M1(T3DN)-S208P [desig-
nated M1(T1L,P208S)WT and M1(T3D,S208P)WT in this
report] have been described previously (Parker et al., 2002) and
encode μ2 proteins with the same amino acid sequences as those
of the T1L and T3D reoviruses from our lab except for the
indicated swaps of Pro and Ser at position 208. Plasmid M1
(T1L,P208S)WO was made by digesting plasmid M1(T1L)WO
with AflIII followed by SacII; the fragment of this sequential
digest containing the wobble mutations was then inserted into
the same digest of M1(T1L,P208S)WT. Plasmid M1(T3D,
S208P)WO was made by digesting plasmid M1(T3D)WO with
SalI, which cuts twice; the fragment of this digest containing the
silent mutations was then ligated into a SalI-digested M1(T3D,
S208P)WT that had been treated with calf intestinal phospha-
tase. The presence of the respective mutations in the two final
plasmids was confirmed by sequencing.
siRNA transfection followed by reovirus infection
The following general protocol was modified from one
initially developed for studies of the reovirus μNS protein (M.
M. Arnold and M. L. Nibert, manuscript in preparation). Duplex
siRNAs containing sequences positioned within the open
reading frame of the M1 gene segment were purchased from
Dharmacon, after being designed according to the company's
highest criteria score (Fig. 1a). Typically in siRNA experiments,
CV-1 cells were grown to near confluency in 75-cm3 flasks.
Cells were released from the flask with trypsin/EDTA solution
(Irvine Scientific), harvested by pelleting at 1500 rpm, and
prepared for transfection. A 400-μl volume of siRNA and/or
plasmid DNA in DMEM lacking antibiotic was added to the
cells and transfected via electroporation using a Gene Pulser II
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In most cases, 4.5 μg (300 nM) of siRNA and 5 μg of plasmid
DNAwere used for transfections. Samples were then incubated
for 24 h post-transfection (p.t.) before subsequent infections. At
24 h p.t., the transfection mixture was removed from the
samples and saved for future use. The cells were rinsed twice
with phosphate-buffered saline (PBS) [137 mM NaCl, 3 mM
KCl, 8 mM Na2HPO4 (pH 7.5)] containing 2 mM MgCl2 and
then infected with T1L or T3D reovirus at 10 PFU/cell. The
virus was adsorbed for 1 h at room temperature before the
transfection mixture was returned to the samples. The infected
cells were then incubated at 37 °C for 0, 24, or 48 h before
preparation for viral titer assays. Based on the titer and μ2
expression results, we generally estimated that the transfection
efficiencies for siRNAs and plasmids in these experiments were
>90% and >30%, respectively, with regard to the cells that
were also infected.
Viral titer assays
Infected cells were harvested by scraping at 0, 24, or 48 h
post-infection (p.i.), and the lysates were placed into 1-dram
vials. The samples were then subjected to two cycles of freezing
and thawing, and titered by plaque assays as described
elsewhere (Middleton et al., 2002). Plaques were counted 2 to
4 days later, depending on the reovirus strain. Viral yields were
calculated with the formula log10(PFU/ml)t=xd− log10(PFU/
ml)t=0, where t is time and xd is days p.i.
SDS–PAGE and immunoblotting
siRNA-transfected and/or infected cells were scraped into
the medium, harvested by pelleting at 1500 rpm, and lysed at
4 °C in buffer A [10 mM HEPES–KOH, pH 7.9; 1.5 mM
MgCl2; 10 mM KCl; 1× protease inhibitor cocktail (Roche
Diagnostics), and 1% NP-40] for 30 min with multiple vortex
steps at 5-min intervals. Following lysis, samples were prepared
in SDS gel loading buffer for electrophoresis on a 10%
polyacrylamide gel. Proteins were then transferred from gels
onto nitrocellulose membranes, and the blots were soaked in 1×
Tris-buffered saline plus Tween (TBST) (20 mM Tris, pH 7.5;
500 mM NaCl; 1% Tween-20) containing 5% milk before
addition of antibodies in 1× TBST containing 1% milk. 1×
TBST containing 1% milk was also used in subsequent washes.
Binding of primary antibody was detected with HRP-con-
jugated secondary antibodies and SuperSignal Chemilumines-
cence reagent (Pierce) or by using alkaline phosphatase-coupled
donkey anti-rabbit (Bio-Rad) and the colorimetric reagents
p-nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indo-
lylphosphate p-toluidine salt (Bio-Rad).
Indirect immunofluorescence microscopy and viral dsRNA
synthesis
Cells to be processed for immunofluorescence microscopy
were fixed for 10 min at room temperature in 2% paraformal-
dehyde. Fixed cells were washed with PBS and permeabilizedand blocked in PBS containing 1% bovine serum albumin and
0.1% Triton X-100 (PBSA–0.1%TX100). Primary antibodies
were diluted in PBSA–0.1%TX100 and incubated with the cells
for 45 min at 37 °C. After three washes in PBS, secondary
antibodies diluted in PBSA–0.1%TX100 were added and
incubated with the cells for 45 min at 37 °C. Cover slips were
incubated with 300 nM DAPI (4,6-diamidino-2-phenylindole;
Molecular Probes) in PBS for 10 min to counterstain the cell
nuclei, washed in PBS, and then mounted on glass slides with
Prolong (Molecular Probes). Samples were examined with a
60×, 1.4 NA objective using a Nikon TE-2000U inverted
microscope equipped with phase and fluorescence optics.
Images were collected digitally using a cooled, charge-coupled
device camera (Hamamatsu Corp.) and analyzed with Meta-
morph 6.1 (Molecular Devices). All images were processed and
prepared for presentation using Photoshop 5.5 (Adobe Systems,
Inc.).
For dsRNA analysis, cell lysates were collected at indicated
times after infection using TrizolLS reagent according to the
manufacturer's instructions (Invitrogen). Samples were heated
to 60 °C for 5 min and reovirus dsRNAs were separated in a
10% SDS–PAGE gel. The gel was stained with 0.5 μg/ml
ethidium bromide in TAE buffer (40 mM Tris acetate, pH 8.3,
1 mM EDTA).
Nocodazole treatment
Our lab has previously reported that treatment of CV-1 cells
with concentrations of nocodazole between 500 nM and 10 μM,
for 1 h, resulted in complete depolymerization of cellular
microtubules detected by α-tubulin staining (Parker et al.,
2002). For the current studies, infected cells were treated with
10 μM nocodazole beginning at 6 h p.i. and then incubated with
the drug up to 48 h p.i. as indicated.
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